MDLN · CIK 0002046386
What Medline Inc. told the SEC could break it.
Medline's revenue funnels through a handful of contracts: about $19.7 billion — 69% of consolidated net sales — flows through its three largest group purchasing organizations, Vizient, HealthTrust and Premier, so failing to renew or losing a major GPO relationship would be material. Its supply side is import-heavy and trade-exposed: it imports a significant share of its Medline Brand products from outside the U.S., including 5% of cost of goods sold from China, and tariffs compressed gross margin by 115 basis points in fiscal 2025 (235 on the Medline Brand segment). It also relies on sole suppliers for certain components and raw materials, such as polymers used in its branded products, which are slow to replace because of FDA requalification.
4 self-disclosed vulnerabilities, pulled from its own filings — each in the company’s words, with the source. This is the risk register almost nobody reads.
In its own words
What could break it.
Customer concentration
- 69% of net sales via 3 GPO contractshigh
About $19.7B (69% of consolidated net sales) flows through contracts with three GPOs — Vizient, HealthTrust and Premier; losing or failing to renew a major GPO/provider contract would be material.
“In addition, for the year ended December 31, 2025, approximately $19.7 billion (or 69% of consolidated net sales and 74% of U.S. net sales) was from sales to member hospitals under contract with our largest GPOs: Vizient Supply, LLC, HealthTrust Purchasing Group, L.P., and Premier Healthcare Alliance, L.P.”
SEC filing →As of 2026
Geographic concentration
- imported Medline Brand products incl. 5% of COGS from Chinamedium
Imports a significant share of Medline Brand products from outside the U.S., including 5% of COGS sourced from China in FY2025.
“We import a significant percentage of our Medline Brand products from outside of the United States, including 5% of our costs of goods sold from China for the year ended December 31, 2025.”
Regulatory & policy
- import tariffs — 115 bps gross-margin hit FY2025medium
Tariffs materially compressed margins: gross margin fell from 27.3% to 26.4% in FY2025, driven by 115 bps of higher import costs from tariffs (235 bps on Medline Brand segment EBITDA margin).
“Gross profit as a percentage of sales decreased fr om 27.3% for the year ended December 31, 2024 to 26.4% for the year ended December 31, 2025 , primarily driven by 115 basis points from higher import costs due to tariffs.”
Sole-source dependency
- sole suppliers for polymers & components in Medline Brand productsmedium
Buys certain components and raw materials — such as polymers used in Medline Brand products — from sole suppliers; FDA/regulatory requalification makes replacing them slow.
“In addition, for quality assurance or cost effectiveness, we have purchased from sole suppliers certain components and raw materials, such as polymers used in our Medline Brand products, and we expect to continue to purchase these components and raw materials from these sole suppliers.”
SEC filing →As of 2026
The hidden graph
Who it depends on, and who depends on it.
Relationships surfaced from filings — including ones disclosed by the other side, which is how the non-obvious ones come to light.
Its customers
Premier Healthcare Alliance, L.P. (Premier Inc.)
“In addition, for the year ended December 31, 2025, approximately $19.7 billion (or 69% of consolidated net sales and 74% of U.S. net sales) was from sales to member hospitals under contract with our largest GPOs: Vizient Supply, LLC, HealthTrust Purchasing Group, L.P., and Premier Healthcare Alliance, L.P.”
Cited →Vizient Supply, LLC
“In addition, for the year ended December 31, 2025, approximately $19.7 billion (or 69% of consolidated net sales and 74% of U.S. net sales) was from sales to member hospitals under contract with our largest GPOs: Vizient Supply, LLC, HealthTrust Purchasing Group, L.P., and Premier Healthcare Alliance, L.P.”
Cited →HealthTrust Purchasing Group, L.P.
“In addition, for the year ended December 31, 2025, approximately $19.7 billion (or 69% of consolidated net sales and 74% of U.S. net sales) was from sales to member hospitals under contract with our largest GPOs: Vizient Supply, LLC, HealthTrust Purchasing Group, L.P., and Premier Healthcare Alliance, L.P.”
Cited →
In the MyPRIA app, this is checked against the companies you actually own.
← World Watch